Dr Judy Chou, CEO, President and Board Member of AltruBio, Inc, explains how agonist antibodies show potential as a novel therapeutic approach in immunological diseases.
Disrupting F-actin in aged brains restored brain autophagy to youthful levels and reversed some cellular markers of brain ...
Anirban Datta, Head of Discovery Biology at Verseon International Corporation, details recent breakthroughs in organoid ...
The glaucoma drug methazolamide removed tau build-up and lessened signs of dementia in genetically-engineered zebrafish and mice.
Small molecules are essential for developing effective medicines, but their structural complexity and material behaviour ...
Furthermore, the team identified the signalling pathway by which the protein INPP4B drives the movement of lysosomes to the ...
The Women in Advanced Therapies pre-day at Advanced Therapies Europe 2024 provided a great forum to address investment in ...
The findings offer a promising drug target to prevent progression to colon cancer by targeting abnormal cells early on.
Based on MRI scans from 732 prostate cancer patients, the AI model identified the edges of 85 percent of the most radiologically aggressive lesions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback